[1]
2024. The PERSPECTIVES OF BIOTECHNOLOGICAL DEVELOPMENT IN KAZAKHSTAN IN TERMS OF MONOCLONAL AND OTHER RECOMBINANT ANTIBODIES AND VACCINES AGAINST SARS-COV2. Experimental biology. 99, 2 (Jun. 2024), 173–188. DOI:https://doi.org/10.26577/eb.2024.v99.i2.015.